skip to main content

A top-notch restructuring group, capable of handling the biggest and the most difficult restructuring from either company side or creditors’ side.

- Chambers USA, Band 1 Bankruptcy/Restructuring (Nationwide and NY)

Healthcare & Pharmaceutical

Our restructuring department fields large, multidisciplinary teams that leverage the resources of our firm as a whole. We act on all sides of cutting-edge restructuring transactions across a range of industries.

resource search icon
  • Mallinckrodt's Restructuring

    An ad hoc committee of noteholders of Mallinckrodt, a leading global biopharmaceutical company, in (a) Mallinckrodt’s chapter 11 cases and (b) a prior out-of-court exchange of $495 million of senior unsecured debt for new first lien senior secured notes, on a par-for-par basis.

  • The Medicines Company Chapter 11

    The Medicines Company, a leading biopharmaceutical company, as one of the largest unsecured creditors in the chapter 11 cases of Melinta Therapeutics, a pharmaceutical company focused on antibiotic medicines.

  • One Call Medical's Out-of-Court Restructuring

    Chatham Asset Management in an out-of-court restructuring of One Call Corporation, a leader in ancillary services for the workers’ compensation industry and ancillary services for Medicare and Medicad, that eliminated nearly $1 billion of the company’s outstanding debt.

  • Trident's Chapter 11 Cases

    Silver Point Capital, as postpetition and senior prepetition lender, in the restructuring of Trident and its affiliates, the leading national provider of bedside diagnostic and related health care services, including its chapter 11 cases.

  • Egalet's Prearranged Chapter 11 Cases

    An ad hoc group of first lien noteholders of Egalet, a specialty pharmaceutical company, in Egalet's prearranged chapter 11 cases.

  • RCCH HealthCare Partners’ Acquisition of Kennewick Public Hospital District

    RCCH HealthCare Partners, a Tennessee-based provider of hospital and healthcare services, in its acquisition of substantially all of the assets of chapter 9 debtor Kennewick Public Hospital District (d/b/a Trios Health).

  • Concordia Healthcare's Restructuring

    An ad hoc group of debtholders of Concordia Healthcare, an international specialty pharmaceutical company based in Canada, in the restructuring of the company and its affiliates.

  • Savient Pharmaceutical's Prearranged Chapter 11 Case

    The ad hoc committee of senior secured noteholders of Savient Pharmaceuticals, a specialty biopharmaceutical company, in the company’s prearranged chapter 11 case. The company implemented an auction process that resulted in a successful sale of substantially all of the company’s assets pursuant to section 363 of the Bankruptcy Code and the distribution of the sale proceeds to the senior secured noteholders.

  • Omni Home Healthcare's Out-of-Court Restructuring

    The sponsors of Omni Home Healthcare, a regional provider of home healthcare services, in the company’s out-of-court restructuring.

  • A Specialty Pharmaceutical Company's Out-of-Court Restructuring

    An ad hoc committee of unsecured creditors of a publicly-traded specialty pharmaceutical company in connection with the potential out-of-court restructuring of over $300 million of secured and unsecured debt.

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy